|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/541 | |
| A61K 9/20 | |||
| A61K 9/48 | |||
| A61K 31/437 |
| (11) | Number of the document | 3102213 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15705777.9 |
| Date of filing the European patent application | 2015-02-04 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/052239 |
| Date | 2015-02-04 |
| (87) | Number | WO 2015/117980 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 201402070 | 2014-02-07 | GB |
| (72) |
DE WEER, Marc Maurice Germain, BE
VRIELYNCK, Sara Bertha Camiel, BE
SABOURAULT, Nicolas Luc, FR
MOESCHWITZER, Jan Peter, DE
|
| (73) |
Galapagos NV,
Generaal De Wittelaan L11/A3, 2800 Mechelen,
BE
|
| (54) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |
| PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |